Cite
HARVARD Citation
Pignata, S. et al. (2023). Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial. Lancet oncology. 24 (3), pp. 286-296. [Online].